Categories News Press Releases Archives 2026 August July June May April March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April February January Mar 09 First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis Read More Oct 18 BIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis Read More